Immunosuppressant quantification in intravenous microdialysate

Therapeutic drug monitoring (TDM) plays a crucial role in personalized medicine. It helps clinicians to tailor drug dosage for optimized therapy through understanding the underlying complex pharmacokinetics and pharmacodynamics. Conventional, non-continuous TDM fails to provide real-time information, which is particularly important for the initial phase of immunosuppressant therapy, e.g., with cyclosporine (CsA) and mycophenolic acid (MPA).

Application of optical sensing in POCT

Cornel’s MicroEye(R) microdialysis device is a key factor in enabling therapeutic drug monitoring of immunosuppressants drugs to prevent rejection in transplant patients.

World-changing innovations are just around the corner?

An excellent article in The Times (published Saturday, 27 June, 2020) If biotech transforms our health in the coming decade it will be through the creativity of individuals unconstrained by red tape, says Matt Ridley. I believe it is a extract from his book ‘How Innovation Works’.  He comments that people overestimate the impact of […]